Location History:
- Munchenstein, CH (1998)
- Münchenstein, CH (2001)
Company Filing History:
Years Active: 1998-2001
Title: Innovations and Contributions of Tudor Arvinte
Introduction
Tudor Arvinte is a notable inventor based in Münchenstein, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, his work focuses on enhancing the stability and efficacy of pharmaceutical compositions.
Latest Patents
One of Tudor's latest patents involves the development of transforming growth factor β (TGF-β) crystals. This invention addresses the challenges associated with the soluted form of TGF-β, demonstrating that the crystalline form exhibits less adsorption to vial walls and greater stability against oxidative agents. These TGF-β crystals are valuable for structure determination, drug design, and the production of slow-release pharmaceutical preparations. Another significant patent is for stable dry powders, which provides a freeze-dried pharmaceutical composition comprising hirudin and a water-soluble salt of calcium and/or magnesium. This innovation aims to improve the stability and usability of pharmaceutical products.
Career Highlights
Tudor Arvinte is currently associated with Novartis Corporation, a leading global healthcare company. His work at Novartis has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.
Collaborations
Tudor collaborates with esteemed colleagues such as Peer Mittl and Markus Grüter. Their combined expertise fosters an environment of innovation and advancement in their respective fields.
Conclusion
Tudor Arvinte's contributions to pharmaceutical innovations through his patents reflect his commitment to improving drug stability and efficacy. His work continues to influence the industry positively.